| 8.26 0.16 (1.98%) | 11-29 10:51 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 9.92 | 1-year : | 11.59 |
| Resists | First : | 8.5 | Second : | 9.92 |
| Pivot price | 7.91 |
|||
| Supports | First : | 6.66 | Second : | 5.53 |
| MAs | MA(5) : | 8.14 |
MA(20) : | 7.63 |
| MA(100) : | 8.82  |
MA(250) : | 10.21 |
|
| MACD | MACD : | 0.3 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 79.8 |
D(3) : | 78.3 |
| RSI | RSI(14): 61.2 |
|||
| 52-week | High : | 14.02 | Low : | 5.53 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ DH ] has closed below upper band by 22.9%. Bollinger Bands are 7.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 8.29 - 8.33 | 8.33 - 8.37 |
| Low: | 7.64 - 7.69 | 7.69 - 7.73 |
| Close: | 8.03 - 8.1 | 8.1 - 8.16 |
Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
Fri, 24 Nov 2023
Definitive Healthcare Corp. (NASDAQ:DH) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected - Simply Wall St
Sun, 05 Nov 2023
Definitive Healthcare Corp. (NASDAQ:DH) Q3 2023 Earnings Call Transcript - Yahoo Finance
Fri, 03 Nov 2023
Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big ... - Investing.com UK
Thu, 02 Nov 2023
Definitive Healthcare Reports Financial Results for Third Quarter ... - Yahoo Finance
Fri, 20 Oct 2023
Definitive Healthcare Corp. (DH) Soars 7.1%: Is Further Upside Left in the Stock? - Yahoo Finance
Fri, 06 Oct 2023
Definitive Healthcare Corp. Announces Executive Changes ... - Marketscreener.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Health Information Services
|
|
| Shares Out | 116 (M) |
| Shares Float | 52 (M) |
| Held by Insiders | 1.6 (%) |
| Held by Institutions | 107.4 (%) |
| Shares Short | 5,070 (K) |
| Shares Short P.Month | 6,540 (K) |
| EPS | -1.62 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 7.42 |
| Profit Margin | -74.1 % |
| Operating Margin | -6.9 % |
| Return on Assets (ttm) | -1 % |
| Return on Equity (ttm) | -20.2 % |
| Qtrly Rev. Growth | 13.8 % |
| Gross Profit (p.s.) | 1.69 |
| Sales Per Share | 2.11 |
| EBITDA (p.s.) | 0.17 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 32 (M) |
| Levered Free Cash Flow | 80 (M) |
| PE Ratio | -5.21 |
| PEG Ratio | 0.5 |
| Price to Book value | 1.12 |
| Price to Sales | 3.96 |
| Price to Cash Flow | 30.21 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|